Brief: Scandinavian Chemotech Q3 Pretax Loss Roughly Unchanged At SEK 5.6 Mln
22/11/2022 07:41
Nov 22 (Reuters) - Scandinavian ChemoTech AB CMOTECb.ST :
* Q3 PRETAX LOSS SEK 5.6 MILLION VERSUS LOSS SEK 5.7 MILLION YEAR AGO
* Q3 NET SALES SEK 119,000 VERSUS SEK 9,000 YEAR AGO
Source text for Eikon: ID:nWkr4pbbpp
Further company coverage: CMOTECb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Scandinavian ChemoTech AB
See all newsBrief: Chemotech Enters Strategic Partnership With University Of Copenhagen's Veterinary Hospitals
Brief: Scandinavian Chemotech Secures SEK 6 Mln Growth Loan
Brief: ChemoTech: Outcome Of Directed Issue
Sweden's ChemoTech Q1 net sales rise, loss narrows on US operation improvement
Brief: ChemoTech Q1 Sales SEK 2.798 Million